2017 Meeting Menu
Plenary & Keynote Speakers
Plenary & Keynote Speakers at the 34th Annual Meeting of the Society of Thermal Medicine are supported by the JAYNE KOSKINAS TED GIOVANIS FOUNDATION FOR HEALTH AND POLICY, a Maryland private foundation dedicated to effecting change in health care for the public good. The opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and not necessarily those of the JAYNE KOSKINAS TED GIOVANIS FOUNDATION FOR HEALTH AND POLICY, its directors, officers, or staff.
KEYNOTE SPEAKER
Dr. Ricardo Bentes de Azevedo
Dr. Ricardo Bentes Azevedo received his Ph.D. degree from the University of Sao Paulo, Brazil with focused studies in Tissue and Cell Biology. He completed post-doctoral training at the National Institutes of Health (NIH) in Bethesda, Maryland, USA. Currently Dr. Azevedo is a scholar of the Brazilian National Council for Science and Technology (CNPq), he is the National Coordinator of the Brazilian Institute of Science and Technology (INCT) in Nanobiotechnology, and he holds a full Professor Chair in the Institute of Biological Sciences, at the University of Brasilia. The main focus of his research is biological and biomedical applications of nanostructured materials for drug delivery, imaging, and diagnosis. An area of intense interest in nanotechnology applications for Dr. Azevedo is the search for alternative treatments for cancer, microbial diseases, and treatment of environmental contamination using nanostructured materials as delivery agents of novel compounds derived from native plants and as mediators of complex chemical interactions. Dr. Azevedo’s work has been cited over 3,000 times with over one hundred fifty published papers in varied scientific journals, including Nature, Biomaterials, Journal of Biological Chemistry, Nanomedicine, Nanoscale, Journal of Biomedical Nanotechnology, and many others.
Dr. Ingrid Hilger
Keynote Speaker
Prof. Dr. Ingrid Hilger is head of the Department „Experimental Radiology“ at the University Hospital Jena, Germany. Born in Argentina, she studied biology at the Christian-Albrechts-University in Kiel, Germany, and received her diploma in 1990. She performed several studies in biology in South America and Asia. Later on, she got interested in human biology and biochemistry received her PhD at the University Hospital Hannover, Germany, in 1996. Since then, she focused her research activities to the areas of therapeutic nanotechnology and of in vivo meso/macroscopic optical molecular imaging and preclinical imaging in general. Since 2008, she is full professor at the University Hospital Jena, Germany. She was awarded the Walter Friedrich Prize in 2003 and an International Patent Innovation Prize in 2016. She is the spokesmen of the German Molecular Imaging Network and the German representative of the European Society of Molecular Imaging.
Dr. Elder de la Rosa
Keynote Speaker
Prof. Elder De la Rosa was born in Mexico in 1964. He received a PhD degree in 1998 from Centro de Investigaciones en Optica (CIO) and received a postdoctoral position at UNAM in 1999. He joined CIO in 2000 as a fulltime professor and has been the General Director since
November 23, 2012. He is the founder of CIO’s research group on Nanophotonics and Advanced Materials (NAFOMA). His research interests are linear and non-linear properties of advanced materials for photonic applications along with the synthesis and characterization of luminescence in nanostructured materials (oxides, semiconductors, metals) for lighting systems, solar cells, biosensing, biomedical applications, and preparation and characterization of luminescence in soft glasses (P2O5, TeO2) doped with rare-earths for optic fiber amplifiers and lasers. He is SPIE fellow member since 2017, and member of SNI level III. He has published over 130 peer-reviewed scientific papers and has been cited more than 3000 times. He has also graduated 14 PhD and 13 MSc students. Prof. De la Rosa has been an invited editor from Optical Materials and Journal Nanoscience and Nanotechnology. Since 2004, he has been organizing annually the Topical Meeting on Nanoscience and Nanostructured Materials.
Dr. Robert Clarke - Plenary Speaker
Robert Clarke is Professor of Oncology at Georgetown University (Washington, DC, U.S.A), Co-Leader of the Breast Cancer Program at the Georgetown Lombardi Comprehensive Cancer Center, and Dean for Research at Georgetown University Medical Center (GUMC). A Senior Editor for the journal, Cancer Research, Dr. Clarke serves on the boards of over a dozen international scientific journals. He regularly serves on state, national, and international grant peer-review study sections; completing his term as chair of an N.I.H. grant peer-review study section in 2008 (2002-2008; National Center for Complementary and Alternative Medicine) and again in 2013 (2011-2013; Basic Mechanisms of Cancer Therapeutics). Regularly invited to speak about his research at international and national meetings, he served a two year term as the elected NCI-SigmaXi Distinguished Lecturer (2012-2014). Dr. Clarke takes a systems biology approach to studying how hormones (endogenous and exogenous) and related factors affect breast cancer. He and his colleagues have recently defined a unified model of the hormonal regulation of breast cancer cell proliferation and cell death in response to estrogens, aromatase inhibitors, and antiestrogens. This signaling represents communication between endoplasmic reticulum and mitochondria, and reflects novel interactions among the unfolded protein response, autophagy, and cellular metabolism.
Dr. Elizabeth Repasky - Plenary Speaker
Dr. Elizabeth Repasky is a Professor of Oncology, the William Huebsch Professor of Immunology, and a Program Leader for the Cell Stress and Biophysical Therapies Program at Roswell Park Cancer Institute (RPCI). Dr. Repasky’s research program focuses on exploration of physiological responses which can be manipulated to alter the tumor microenvironment and improve the efficacy of cancer therapies, including immunotherapies. A major passion for her has been to understand the role of body temperature and the impact of mild thermal stress (hyperthermia and heat shock response) on anti-tumor immune activity, vascular function and metabolism. During her career, she has authored or co-authored over 170 cited publications. Dr. Repasky is a recent awardee of the J. Eugene Robinson Award from the Society for Thermal Medicine. Training and mentorship have been passions for her during her career and she has served as major advisor to 20 PhD students and 8 Postdoctoral Fellows who have gone on to become successful members of the research, academia or bio-tech communities. Several of her trainees are now members of the Society for Thermal Medicine.
Dr. Denis Wirtz - Plenary Speaker
Denis Wirtz is the vice provost for research and a professor of chemical and biomolecular engineering at The Johns Hopkins University. He also directs the Johns Hopkins Physical Sciences-Oncology Center and co-directs the Cancer Nanotechnology Training Center, both National Cancer Institute-funded entities. Wirtz holds the T.H. Smoot Professorship in the Whiting School of Engineering’s Department of Chemical and Biomolecular Engineering, and has secondary appointments in the School of Medicine’s Departments of Oncology and Pathology. Wirtz earned his B.Sc. in Engineering Physics from the Université Libre de Bruxelles in Belgium and M.Sc. and Ph.D. degrees in Chemical Engineering from Stanford University. He studies the biophysical properties of healthy and diseased cells, including interactions between adjacent cells and the role of cellular architecture on nuclear shape and gene expression. Cell biophysics, single molecule manipulation, intracellular particle trafficking, instrument development, tissue engineering, and nanotechnology in biology and medicine are among his research interests. He has authored more than 200 peer-reviewed articles, and his research has been cited more than 14,000 times.
34th Annual Society for Thermal Medicine Meeting
MAIN SPONSOR
We have received a generous donation from the Jayne Koskinas Ted Giovanis Foundation for Health and Policy (JKTG) to sponsor New Investigator Travel Awards (15), our Keynote and Plenary speakers, our Refresher Workshop, and our non-member invited speakers.
We wish to thank the JKTG for their generous support of our meeting!
Supported by the JAYNE KOSKINAS TED GIOVANIS FOUNDATION FOR HEALTH AND POLICY, a Maryland private foundation dedicated to effecting change in health care for the public good. The opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and not necessarily those of the JAYNE KOSKINAS TED GIOVANIS FOUNDATION FOR HEALTH AND POLICY, its directors, officers, or staff.
Dear Friends and Supporters of STM,
On behalf of my fellow members of STM Governing Council and meeting Planning Committee, it is my distinct pleasure to invite you to join us for our 34th Annual Meeting in Cancún, Mexico at the CasaMagna Marriott Cancún Resort, April 29 – May 2, 2017. The conference is shaping up to feature an outstanding line-up of the world’s thought leaders and prominent researchers presenting cutting-edge developments in biology, physics, engineering, and clinical applications of thermal medicine.
Several meeting sessions will be disease specific to attract participation by clinicians from around the world. These sessions will highlight the latest results of Phase III clinical trials combining hyperthermia with radiation or chemotherapy to treat breast, cervical, liver, brain, and pediatric cancers. Immunotherapy, one of the most exciting developments in clinical management of cancer, will be featured in special symposia with presentations by leading clinicians and researchers. Other sessions will be technology oriented, to focus on existing and emerging technologies in thermal medicine. Focused ultrasound, laser, and microwave device innovations to deliver heat energy for disease management will be featured. One of our most exciting and rapidly growing technology-focus areas is nanotechnology. We have sessions highlighting the latest developments in nanotechnology and nanobiotechnology applied to imaging and therapy of cancer with thermal medicine. Nanothermometry, another cutting-edge innovative technology area will have its own special symposium. We view “thermal medicine” as a continuum encompassing many fields of science and technology from cryotherapy, hyperthermia, and thermal ablation, which includes heat directed drug delivery and immunotherapy. The program will reflect this perspective.
Another objective of the 34th Annual Meeting is to highlight the growing global penetration of scientific and clinical applications of thermal medicine. The location and key invited speakers for the 34th Annual Meeting were carefully chosen to emphasize scientific exchange among the Americas, Europe, and Asia. Our roster of invited speakers includes prominent clinicians and leading experts in biology, medicine, engineering, and nanotechnology from countries in Europe, Asia, South and North America.
We look forward to seeing you in Cancún!
Sincerely,
Robert Ivkov, PhD
Program Chair, President-Elect, Society for Thermal Medicine
2017 Corporate Partners
Gold Level
Silver Level
Bronze Level
Friends Level
Other Contributors
2017 New Investigator Travel Award Winners
Mrs. Arlene Oei
Hyperthermia affects both BRCA2-proficient and
BRCA2-deficient cell lines
Department of Radiation Oncology, AMC
Amsterdam
The Netherlands
Dr. Elizabeth Sweeney
Eliciting immunogenic cell death using Prussian blue nanoparticle-based photothermal therapy and the implications for cancer therapy
Children’s National Health System
Washington, DC
USA
Dr. Li Tian
Co-delivery of nanoparticulated NVP BEZ-235 decreases cell proliferation of irreversible electroporation treated xenograft
The University of Texas MD Anderson Cancer Center
Houston, Texas
USA
Dr. Bettina Weigelin
Activating serial killers of cancer cells: Hyperthermia as supporting strategy for cancer immunotherapy
MD Anderson Cancer Center
Houston, Texas
USA
2017 Program Chair
Robert Ivkov, PhD
2017 Program Chair,
President-Elect,
Society for Thermal Medicine
Johns Hopkins University
School of Medicine
Department of Radiation Oncology
Baltimore,MD
Associate Editor, International Journal of Hyperthermia
Email:rivkov1@jhmi.edu
Planning Committee
Program Chair: Robert Ivkov, PhD, Johns Hopkins University School of Medicine Department of Radiation Oncology
Corporate Relations & Fundraising Chair: Zeljko Vujaskovic, MD, PhD, University of Maryland
Andris Bakuzis, PhD, Institute of Physics, Federal University of Goias, Brazil
Randy Burd, PhD, The University of Arizona Cancer Center
Erik Cressman, MD, PhD, University of Texas MD Anderson Cancer Center
Chris Diederich, PhD, University of California San Francisco
Steven Fiering, PhD, Geisel School of Medicine, Dartmouth College
Robert Griffin, PhD, University of Arkansas for Medical Sciences
Dieter Haemmerich, PhD, Medical University of South Carolina
Mark Hurwitz, MD, Thomas Jefferson University Hospitals
William Nau, PhD, Medtronic Minimally Invasive Therapies Group
Jason Stafford, MD, University of Texas MD Anderson Cancer Center
Paul Stauffer, PhD, Thomas Jefferson University
Christopher Lapine, STM Business Manager, Allen Press, Inc.
Joshua Hilbrand, Meeting Planner, K-State Conference Services
2017 New Investigator Travel Award Winners
We are pleased to announce that The Society for Thermal Medicine, with funding from the Jayne Koskinas Ted Giovanis Foundation for Health and Policy, is providing travel grants to 15 New Investigators to encourage participation at the 2017 STM annual meeting.
Awardees will receive a $500 travel grant and registration to the meeting.
Travel Awards recipients are based upon a competitive evaluation of their submitted abstracts and New Investigator Award applications.
Dr. Hale Arca
Novel Photo-induced Chemotherapy Delivery Matrix for Support of Abdominal Organs following Cytoreductive Surgery
Wake Forest School of Medicine
Winston Salem, North Carolina
USA
Dr. James Barnett
Temperature-dependent activation of DNA damage repair in human colorectal cancer cells
Johns Hopkins University School of Medicine
Baltimore, Maryland
USA
Dr. Steven Brousell
Synergistic Immuno-Photothermal Nanotherapy (SYMPHONY): A Novel Treatment for Localized and Metastatic Bladder Cancer
Duke University
Durham, North Carolina
USA
Ms. Juliana Cano-Mejia
Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma
University of Maryland
Hyattsville, Maryland
USA
Dr. Bingbing Cheng
Development of a remote acoustic sensing safety mechanism for biofilm eradication using alternating magnetic fields
University of Texas Southwestern Medical Center
Dallas, Texas
USA
Ms. EunYoung Koh
Development of the thermosensitizer for maximizing cancer treatment efficacy with the radiofrequency-induced hyperthermia
Jeonbuk National University
Jenonju-Si, Jeollabik-Do
Republic of Korea
Dr. Satya VVN Kothapalli
Identification of clinical MR-HIFU hyperthermia treatment sites through validation of MR thermometry accuracy and precision in healthy volunteers
Washington University in Saint Louis
Saint Louis, Missouri
USA
Ms. Jessie Lee
Compact Ultrasound Applicator for Hyperthermia Treatment of the Transgenic Adenocarcinoma Mouse Prostate Model (TRAMP) with MR Thermometry in a 14T MRI Scanner
University of California San Francisco
San Francisco, CA
USA
Dr. Jason Molitoris
Radiation Therapy plus External Thermal Therapy Results
in Modest Toxicities with the Promise of
Increased Efficacy: A Single Institutional Experience
University of Maryland Medical Center
Baltimore, Maryland
USA
Mr. Anjan Motamarry
In vivo fluorescence imaging predicts drug uptake for temperature sensitive liposomal doxorubicin
Medical University of South Carolina
Charlestom, South Carolina
USA
Dr. Imalka Munaweera
Temperature-Sensitive Liposomal Ciprofloxacin for the Treatment of Biofilm on Prosthetic Joint Implants using Alternating Magnetic Fields
University of Texas Southwestern Medical Center
Dallas, Texas
USA